Are Clexane (Enoxaparin) and Enoxaparin the same medication?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Clexane and Enoxaparin Are the Same Medication

Clexane is simply a brand name for enoxaparin sodium, the generic drug name—they are identical medications with the same active pharmaceutical ingredient. 1

Understanding the Nomenclature

  • Enoxaparin is the generic (chemical) name for this low-molecular-weight heparin, while Clexane is one of several brand names used internationally 1
  • In the United States, this same medication is marketed under the brand name Lovenox 1
  • All formulations contain enoxaparin sodium as the active ingredient, manufactured through alkaline hydrolysis of the benzyl ester of unfractionated heparin 2

Pharmacological Identity

  • Whether labeled as Clexane, Lovenox, or generic enoxaparin, the medication has identical pharmacological properties: a 4:1 ratio of Factor Xa to thrombin activity, reduced binding to plasma proteins compared to unfractionated heparin, and a longer half-life 3
  • The manufacturing process (benzylation followed by alkaline depolymerization) produces the same molecular weight distribution and anti-Xa/anti-IIa ratios regardless of brand name 4

Critical Caveat: Biosimilar Products

  • Not all "enoxaparin" products are necessarily identical—biosimilar versions of enoxaparin exist that may have subtle differences in compositional profile, even though they share the same generic name 3
  • The International Society on Thrombosis and Haemostasis requires biosimilar enoxaparin products to demonstrate identical compositional profiles, pass preclinical investigations, and potentially undergo clinical trials if any differences are detected 3
  • When switching between originator enoxaparin (Clexane/Lovenox) and biosimilar versions, exercise caution as outcomes cannot be extrapolated between different patient populations, and at least one major bleeding complication has been reported following such a switch 3

Practical Implications

  • Prescriptions written for "enoxaparin," "Clexane," or "Lovenox" can be filled interchangeably with the originator product in most healthcare systems 1
  • All dosing recommendations, clinical trial data, and safety profiles apply equally whether the medication is labeled Clexane or enoxaparin 2, 5
  • The American Heart Association and other guideline societies use "enoxaparin" in their recommendations, which applies to all brand formulations of the originator product 3, 6

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.